SCHEMBL18370779

SCHEMBL18370779

c1ccc(-c2cccc(-c3cccc(-c4cccc(-c5nc(-c6ccccc6)c6c(n5)sc5ccccc56)c4)c3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 8/20 0.40
▸ ADORA1 P30542 7/20 0.40
▸ HPGD P15428 3/20 0.37
▸ WHR1 P49842 1/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ ATM Q13315 1/20 0.35
▸ ELANE P08246 1/20 0.35
▸ GP6 Q9HCN6 1/20 0.35
▸ ADORA3 P0DMS8 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ CASP3 P42574 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33
▸ RELA Q04206 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18370747 1.00 ADORA2A (0.40) ADORA2AADORA1HPGDWHR1MEN1
SCHEMBL18370718 1.00 ADORA2A (0.40) ADORA2AADORA1HPGDWHR1MEN1
SCHEMBL18370801 1.00 ADORA2A (0.40) ADORA2AADORA1HPGDWHR1MEN1
SCHEMBL18370763 0.99 ADORA2A (0.39) ADORA2AADORA1HPGDWHR1MEN1
SCHEMBL18017852 0.99 ADORA2A (0.39) ADORA2AADORA1HPGDWHR1MEN1
SCHEMBL18370785 0.99 ADORA2A (0.39) ADORA2AADORA1HPGDWHR1MEN1
SCHEMBL18370754 0.99 ADORA2A (0.39) ADORA2AADORA1HPGDWHR1MEN1
SCHEMBL18370749 0.99 ADORA2A (0.39) ADORA2AADORA1HPGDWHR1MEN1
SCHEMBL18370786 0.99 ADORA2A (0.39) ADORA2AADORA1HPGDWHR1MEN1
SCHEMBL18017990 0.99 ADORA2A (0.39) ADORA2AADORA1HPGDWHR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same DUK SAN NEOLUX CO., LTD (KR) 2020-08-04 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170012216-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2017-01-12 — — US disclosed
US-20170012216-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2017-01-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME NFE2L2, ESR1, VDAC2 ADORA2A 4441/4885ADORA1 4054/4885HPGD 3291/4885
US-20170012216-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ADORA2A 4711/4885ADORA1 4810/4885HPGD 1502/4885
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same NFE2L2, ESR1, VDAC2 ADORA2A 4441/4885ADORA1 4054/4885HPGD 3291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback